BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12901482)

  • 21. [Substitution therapy in drug addictions].
    Auriacombe M; Fatseas M; Franques-Rénéric P; Daulouède JP; Tignol J
    Rev Prat; 2003 Jun; 53(12):1327-34. PubMed ID: 12920942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of opioid addiction in physicians' offices: it's about time.
    Schnoll SH
    J Addict Dis; 2001; 20(2):1-3. PubMed ID: 11318393
    [No Abstract]   [Full Text] [Related]  

  • 23. Prenatal exposure to methadone and buprenorphine: a review of the potential effects on cognitive development.
    Konijnenberg C; Melinder A
    Child Neuropsychol; 2011; 17(5):495-519. PubMed ID: 21480011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of interventions on opiate withdrawal treatment: an overview of systematic reviews.
    Amato L; Davoli M; Ferri M; Gowing L; Perucci CA
    Drug Alcohol Depend; 2004 Mar; 73(3):219-26. PubMed ID: 15036544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buprenorphine for opioid dependence.
    Milne M; Crouch BI; Caravati EM
    J Pain Palliat Care Pharmacother; 2009; 23(2):153-5. PubMed ID: 19492216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing overdose mortality associated with methadone and buprenorphine treatment.
    Bell JR; Butler B; Lawrance A; Batey R; Salmelainen P
    Drug Alcohol Depend; 2009 Sep; 104(1-2):73-7. PubMed ID: 19443138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates.
    Winklbaur B; Kopf N; Ebner N; Jung E; Thau K; Fischer G
    Addiction; 2008 Sep; 103(9):1429-40. PubMed ID: 18783498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients.
    Soyka M; Apelt SM; Lieb M; Wittchen HU
    J Clin Psychopharmacol; 2006 Dec; 26(6):657-60. PubMed ID: 17110826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence.
    Turner BJ; Laine C; Lin YT; Lynch K
    Arch Intern Med; 2005 Aug 8-22; 165(15):1769-76. PubMed ID: 16087826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Blessing or problem child? Substitution therapy for opiate-addicted patients].
    Pallenbach E
    Pharm Unserer Zeit; 2002; 31(1):90-5. PubMed ID: 11852662
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinic-based treatment for opioid dependence: a qualitative inquiry.
    McMurphy S; Shea J; Switzer J; Turner BJ
    Am J Health Behav; 2006; 30(5):544-54. PubMed ID: 16893317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current Best Practices for Acute and Chronic Management of Patients with Opioid Use Disorder.
    Peterkin A; Laks J; Weinstein ZM
    Med Clin North Am; 2022 Jan; 106(1):61-80. PubMed ID: 34823735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.
    Whitley SD; Kunins HV; Arnsten JH; Gourevitch MN
    J Subst Abuse Treat; 2007 Jul; 33(1):85-90. PubMed ID: 17588493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcohol use disorders in opioid maintenance therapy: prevalence, clinical correlates and treatment.
    Soyka M
    Eur Addict Res; 2015; 21(2):78-87. PubMed ID: 25413371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bupreorphine:a new pharmacotherapy for opioid addictions treatment.
    Stock C; Shum JH
    J Pain Palliat Care Pharmacother; 2004; 18(3):35-54. PubMed ID: 15364630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy.
    Harrison TK; Kornfeld H; Aggarwal AK; Lembke A
    Anesthesiol Clin; 2018 Sep; 36(3):345-359. PubMed ID: 30092933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
    Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treating opioid dependence--new data and new opportunities.
    O'Connor PG
    N Engl J Med; 2000 Nov; 343(18):1332-4. PubMed ID: 11058680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.